Literature DB >> 16289585

Estrogen prevents glutamate-induced apoptosis in C6 glioma cells by a receptor-mediated mechanism.

E A Sribnick1, S K Ray, N L Banik.   

Abstract

Estrogen-mediated neuroprotection is well established; however, no single mechanism of action for this effect has yet been established. As glial cells are integral for both the intact and injured nervous system, we hypothesized that estrogen-mediated neuroprotection may partly be attributed to attenuation of glial cell apoptosis, allowing them to protect neurons following injury. To assess the protective effects of estrogen on glia, C6 rat glioma cells were treated for 24 h with 500 microM glutamate. Cell viability was determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay, and apoptosis was confirmed by cell morphology and DNA fragmentation. Pretreatment with 10 nM 17beta-estradiol (estrogen) increased cell viability and attenuated apoptosis. Treatment with the stereoisomer 17alpha-estradiol, or estrogen plus estrogen receptor antagonist ICI 182,780, was significantly less effective, indicating that cytoprotection was receptor-mediated. Estrogen treatment upregulated expression of estrogen receptor alpha. Cell impermeable bovine serum albumin-conjugated estrogen was also protective, indicating activation of estrogen receptors on the cell membrane. Intracellular free [Ca2+] was increased after glutamate treatment. This increase was attenuated in cells pretreated with estrogen. Glutamate increased the activity of pro-apoptotic proteases, such as calpain and caspase-3, and these protease activities were significantly attenuated by estrogen. The mechanism by which estrogen decreased intracellular Ca2+ was examined by assaying cell viability after using inhibitors that either blocked extracellular Ca2+ influx or prevented the release of intracellular Ca2+ stores. While several inhibitors increased cell viability in glutamate-treated cells, none were as protective as estrogen, and estrogen co-treatment significantly increased cell viability. These findings indicate that estrogen-mediated cytoprotection may be related to effects on Ca2+ entry but that these effects are not limited to any one of these Ca2+ entry points alone.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16289585     DOI: 10.1016/j.neuroscience.2005.08.074

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  22 in total

1.  Tibolone Reduces Oxidative Damage and Inflammation in Microglia Stimulated with Palmitic Acid through Mechanisms Involving Estrogen Receptor Beta.

Authors:  Oscar Hidalgo-Lanussa; Marco Ávila-Rodriguez; Eliana Baez-Jurado; Jairo Zamudio; Valentina Echeverria; Luis Miguel Garcia-Segura; George E Barreto
Journal:  Mol Neurobiol       Date:  2017-09-25       Impact factor: 5.590

2.  Continuous tamoxifen delivery improves locomotor recovery 6h after spinal cord injury by neuronal and glial mechanisms in male rats.

Authors:  Jennifer M Colón; Pablo A González; Ámbar Cajigas; Wanda I Maldonado; Aranza I Torrado; José M Santiago; Iris K Salgado; Jorge D Miranda
Journal:  Exp Neurol       Date:  2017-10-13       Impact factor: 5.330

3.  Molecular mechanisms underlying the α-tomatine-directed apoptosis in human malignant glioblastoma cell lines A172 and U-118 MG.

Authors:  Fa-Zhao Wang; Xue-Liang Dai; Hong-Yi Liu
Journal:  Exp Ther Med       Date:  2017-10-12       Impact factor: 2.447

4.  Estradiol induces JNK-dependent apoptosis in glioblastoma cells.

Authors:  Nedret Altiok; Melike Ersoz; Meral Koyuturk
Journal:  Oncol Lett       Date:  2011-08-17       Impact factor: 2.967

5.  Estrogen attenuates glutamate-induced cell death by inhibiting Ca2+ influx through L-type voltage-gated Ca2+ channels.

Authors:  Eric A Sribnick; Angelo M Del Re; Swapan K Ray; John J Woodward; Naren L Banik
Journal:  Brain Res       Date:  2009-04-21       Impact factor: 3.252

6.  Postinjury estrogen treatment of chronic spinal cord injury improves locomotor function in rats.

Authors:  Eric A Sribnick; Supriti Samantaray; Arabinda Das; Joshua Smith; D Denise Matzelle; Swapan K Ray; Naren L Banik
Journal:  J Neurosci Res       Date:  2010-06       Impact factor: 4.164

7.  A transcriptional fingerprint of estrogen in human breast cancer predicts patient survival.

Authors:  Jianjun Yu; Jindan Yu; Kevin E Cordero; Michael D Johnson; Debashis Ghosh; James M Rae; Arul M Chinnaiyan; Marc E Lippman
Journal:  Neoplasia       Date:  2008-01       Impact factor: 5.715

8.  The parkinsonian neurotoxin rotenone activates calpain and caspase-3 leading to motoneuron degeneration in spinal cord of Lewis rats.

Authors:  S Samantaray; V H Knaryan; M K Guyton; D D Matzelle; S K Ray; N L Banik
Journal:  Neuroscience       Date:  2007-03-23       Impact factor: 3.590

9.  Cell Models for the Study of Sex Steroid Hormone Neurobiology.

Authors:  Chang Su; Nataliya Rybalchenko; Derek A Schreihofer; Meharvan Singh; Babak Abbassi; Rebecca L Cunningham
Journal:  J Steroids Horm Sci       Date:  2012

10.  Cytoprotective effects of melatonin on C6 astroglial cells exposed to glutamate excitotoxicity and oxidative stress.

Authors:  Arabinda Das; Amogh Belagodu; Russel J Reiter; Swapan K Ray; Naren L Banik
Journal:  J Pineal Res       Date:  2008-03-26       Impact factor: 13.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.